Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
Low-dose haloperidol is known to be effective for the treatment of postoperative nausea and
vomiting (PONV). However, precise dose-response studies have not been completed, especially
in patients at high risk for PONV who require combination therapy. This study sought to
identify the optimal dose of haloperidol that could be combined with dexamethasone without
adverse effects in high-risk PONV patients receiving intravenous patient-controlled
anesthesia (IV PCA) after gynecological laparoscopic surgery.